Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic

Firinu D.;del Giacco S.;
2020-01-01

2020
Tedesco
43
7
255
271
17
Esperti anonimi
internazionale
scientifica
Benralizumab; Covid-19; Dupilumab; Mepolizumab; Omalizumab; Reslizumab; SARS-CoV-2; Telemedicine
Klimek, L.; Pfaar, O.; Worm, M.; Eiwegger, T.; Hagemann, J.; Ollert, M.; Untersmayr, E.; Hoffmann-Sommergruber, K.; Vultaggio, A.; Agache, I.; Bavbek, ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
93
reserved
Files in This Item:
File Size Format  
Klimek2020_Article_AnwendungVonBiologikaBeiAllerg.pdf

Solo gestori archivio

Type: versione editoriale
Size 820.39 kB
Format Adobe PDF
820.39 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie